CPAP resumption after a first termination and impact on all-cause mortality in France.

Journal Information

Full Title: Eur Respir J

Abbreviation: Eur Respir J

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pulmonary Medicine

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest: J-L. Pépin has received lecture fees or conference travel grants from ResMed, Philips, AstraZeneca, Jazz Pharmaceuticals, Agiradom and Bioprojet, and has received unrestricted research funding from ResMed, Philips, GlaxoSmithKline, Bioprojet, Fondation de la Recherche Medicale (Foundation for Medical Research), Direction de la Recherche Clinique du CHU de Grenoble (Research Branch Clinic CHU de Grenoble), and fond de dotation “Agir pour les Maladies Chroniques” (endowment fund “Acting for Chronic Diseases”). A. Malhotra is funded by the NIH, reports income from Eli Lilly, Zoll, Jazz and Livanova related to medical education, and ResMed provided a philanthropic donation to UC San Diego. P.A. Cistulli has an appointment to an endowed academic chair at the University of Sydney that was established from ResMed funding, has received research support from ResMed, SomnoMed and Zephyr Sleep Technologies, and is a consultant to ResMed, SomnoMed, Signifier Medical Technologies and Bayer. R. Tamisier has received consulting fees from ResMed, Inspire, Navigant and Jazz Pharmaceuticals, lecture fees from Agiradom, Elivie, ResMed and Philips, conference travel grants from Agiradom, and unrestricted research grants from ResMed, Vitalaire, Philips, APMC foundation Direction de la recherche Clinique du CHU de Grenoble and inter-regional research university hospital group. A.V. Benjafield, F. Lavergne and A. Josseran are employees of ResMed. P. Rinder, P. Sinel-Boucher and P. Hornus are employees of SEMEIA. S. Bailly has no conflicts of interest to disclose."

Evidence found in paper:

"Support statement: J-L. Pépin, S. Bailly and R. Tamisier are supported by the French National Research Agency in the framework of the “Investissements d'avenir” program (ANR-15-IDEX-02) and the “e-health and integrated care and trajectories medicine and MIAI artificial intelligence” Chairs of excellence from the Grenoble Alpes University Foundation. This work was supported by the endowed fund “Agrir pour les maladies chroniques”. This work has been partially supported by MIAI @ University Grenoble Alpes, (ANR-19-P3IA-0003), and an unrestricted grant from ResMed. Funding information for this article has been deposited with the Crossref Funder Registry."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025